Gemfibrozil (Polaryx)

N/A

Report date: 2026/05/09 20:00:18

Base Information

Drug NameGemfibrozil (Polaryx)
Drug Alias NamePLX-200
ClassificationSmall molecules
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonists
TargetsPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsNeuronal Ceroid-LipofuscinosesTay-Sachs DiseaseSandhoff Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPolaryx Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesPolaryx Therapeutics
Inactive CompaniesN/A
Active IndicationsNeuronal Ceroid-LipofuscinosesTay-Sachs DiseaseSandhoff Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A